 Home > Active Pharmaceutical Ingredients > Antineoplastic Agents > N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine for Sale > Best Quality 99% Venetoclax/ABT-199 CAS:1257044-40-8 for Anti-cancer API

Best Quality 99% Venetoclax/ABT-199 CAS:1257044-40-8 for Anti-cancer API buy - large image1

Best Quality 99% Venetoclax/ABT-199 CAS:1257044-40-8 for Anti-cancer API buy - image1

Best Quality 99% Venetoclax/ABT-199 CAS:1257044-40-8 for Anti-cancer API buy - image2

Best Quality 99% Venetoclax/ABT-199 CAS:1257044-40-8 for Anti-cancer API buy - image3

Best Quality 99% Venetoclax/ABT-199 CAS:1257044-40-8 for Anti-cancer API buy - image4

Best Quality 99% Venetoclax/ABT-199 CAS:1257044-40-8 for Anti-cancer API

Name: Best Quality 99% Venetoclax/ABT-199 CAS:1257044-40-8 for Anti-cancer API
Brand: HyperChem
SKU: pr2604161596
Price: 15 USD
Availability: InStock

TDS 215 Inquiries

Unit Price:

$15-18/G FOB

Get Latest Price 

CAS No.:

1346242-81-6

Grade:

Pharmaceutical Grade

Content:

99.9%

Port:

Hangzhou

Brand:

HyperChem

Packaging:

1g/bag, 20g/bag, 50g/bags or other quantities

Price valid (until):

2028-04-30

Contact Supplier

 Chat Now

Hangzhou Hyper Chemicals Limited

Company Type:

Trader

Location:

China

Qualification:

Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Name	Venetoclax
CAS number	1257044-40-8
Synonym	Venetoclax 1257044-40-8 ABT-199 Venclexta GDC-0199
Related APIs #	Navitoclax S55746 (Bcl-2 inhibitor) APG-2575 Lisaftoclax LY2874455 TAS-120 ARQ 087 BGJ398
Description	Venetoclax is a groundbreaking synthetic compound that has garnered attention for its specificity and efficacy in addressing certain cell growth and survival challenges. As science continues to advance, this compound represents a significant leap in targeted approaches within the field of cellular health and disease management. Description and Mechanism Venetoclax functions as a selective inhibitor, designed to interact with particular proteins that play a key role in cell longevity. These proteins, often overexpressed in unhealthy cells, contribute to the survival and resistance of such cells to traditional management approaches. By inhibiting these proteins, Venetoclax promotes the natural process of programmed cell elimination, focusing on cells that contribute to various disorders. Medical Applications The primary application of Venetoclax is in conditions characterized by excessive or abnormal cell survival. Its applications are usually reserved for instances where conventional methods prove inadequate or when a tailored approach is necessary due to specific molecular characteristics of the condition. Precision Targeting: Venetoclax is predominantly used in cases where there is a clear presence of protein overexpression, allowing for targeted intervention. This specificity reduces impact on healthy cells and focuses on the dysregulated cellular processes. Alternative Strategy: For cases where traditional approaches fail or resistances develop, Venetoclax offers an alternative by providing a different mechanism of action. This can be particularly useful in chronic scenarios requiring ongoing management. Combination Use: Venetoclax is often part of combination strategies to improve outcomes. When used with other compounds, it can have a synergistic effect, enhancing the efficacy of the overall regimen by targeting multiple mechanisms at once. Mechanism of Action Venetoclax works by engaging with and inhibiting specific proteins involved in cell survival pathways. Its action helps initiate the natural cell clearance processes in those cells where these pathways are improperly activated. By restoring this balance, Venetoclax aids in managing conditions that thrive on prolonged and uncontrolled cell survival. Source and Production As a synthetic compound, Venetoclax is produced in laboratory settings through advanced chemical synthesis. This process involves precise formulation to ensure that the compound maintains high specificity and potency. Research and development in this area are critical to optimizing its efficacy and safety. Safety and Efficacy Venetoclax has undergone extensive evaluations to ensure it meets safety and efficacy standards: Preclinical Exploration: Initial studies focus on understanding the compound’s mechanism and its effects on cellular models. These are crucial for determining potential success and guiding further development. Clinical Trials: A series of human trials, divided into phases, assess various factors including optimal dosing, short and long-term safety, and effectiveness across diverse populations. These trials are essential for confirming the real-world applicability and benefits of Venetoclax. Environmental and Ethical Considerations The development and implementation of Venetoclax adhere to stringent ethical and environmental standards. Production processes aim to minimize waste and environmental impact, while ethical guidelines ensure that testing and application prioritize participant safety and informed consent. Conclusion Venetoclax embodies the precision and promise of modern medical research, offering new avenues for managing conditions that involve unchecked cell survival. Its selective mechanism and ability to complement existing strategies make it a valuable tool in a clinician’s arsenal. As our understanding of cellular biology continues to expand, Venetoclax marks a significant step towards refined, personalized approaches in pharmaceuticals. Its development underscores the balance of innovation with ethical responsibility and environmental mindfulness, setting a standard for future advancements in the field. Ongoing research will likely continue to explore and expand the potential uses of Venetoclax, adapting and evolving its application to meet the needs of an ever-changing medical landscape. The story of Venetoclax is a testament to the possibilities at the intersection of science, technology, and medicine.
Molecular Formula	C ₄₅ H ₅₀ ClN ₇ O ₇ S
Molecular Weight	868.4 g/mol
Appearance	White or almost white powder
Quality Standard	Enterprise standard; 99.99%
Shipping Condition	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition	Dry, dark and at 0-28℃ for short term (days to weeks) or 0-8 ℃ for long term (months to years).
Shelf Life	>2 years if stored properly
Sample package	Double plastic bags inside, fiber drum outside, any quantity available.
Commercial package	Aluminium Tin, Fiber drum
Origin	China

Shop USP Quality Standard API Finasteride Powder with CAS 98319-26-7-Detailed Image 2

Shop USP Quality Standard API Finasteride Powder with CAS 98319-26-7-Detailed Image 3

FAQ

Q1. What is the Hyper chem payment term?
T/T advance
LC at sight
DP at sight
Trade assurance
Money gram

Q2. What is Hyper chem shipment policy?
Our policy is to strive for the quickest shipment time possible, with ready stock sample shipment typically going out the same day that your order was placed. Your satisfaction is very important to us.
For non-ready stock, please contact the Hyper Chem sales team to negotiate.

Q3. What hyper chem will provide after shipment?
For sample orders:
After shipment is done, an timely email including:

Track details (Fedex /TNT/DHL/EMS Track number)

Package photo

COA, MSDS, etc

Dispatch date & Estimated arriving time

Shipping invoice

For commercial orders
A full set of shipment documents as well as package photos can be provided
in scan-copy and original, to help customers complete the customs clearance process.

Q4. What is Hyper Chem shipment term?

By Express
DHL  FedEx  TNT  EMS
Fast:5 days around
High cost, door to door service

By Air
Suitable for more than 50kg
Fast :3-7 days Hight cost, port to port, professional broker needed

By Sea
Suitable for more than 500kg
Slow:7-45 days, Low cost, port to port, professional broker needed
We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.

Q5. Does hyper chem provide a shipment return policy?
Yes, we have.
Return Policy: At Hyper chem, your satisfaction is guaranteed. If you are dissatisfied for any reason with a product, please send back the unused portion along with your packing slip and a brief note on why you were dissatisfied within 45 days of purchase for a full refund to:

Q6. What is hyper chem After-sales service
•Documents support: COA ,MSDS, MOA ,MS Report,HNMR Report,SDS,DMF
• Customer Support: Shipment clearance support, quality issue support
• Automated Customer Service: Our worldwide customers enjoy immediate 24/7 access to the HYPER CHEM support team from any location, at any time.

About HyperChem

Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to cater to the requirements of our diverse range of clients.

Among them, our key client industrial sectors around the global are:

Pharmaceuticals
Nutrition Ingredients/ Dietary supplements
Cosmetic Ingredients
Food Ingredients
Veterinary API
Agriculture fertilizer
Custom Synthesis lab supply

HyperChem provides to its wonderful and honorable clients comprehensive purchasing and distribution services which ensure that we are delivering the right generic, raw, or customized product, make sure that we are delivering it at the right time, ensure that it is delivered in the specified amount, and in the right kind of packaging to clients and customers of all types of industries irrespective of their size of operation.

ECHEMI Editorial Reference

Erdafitinib (JNJ-42756493) is a potent and orally available FGFR family inhibitor; inhibits FGFR1/2/3/4 with IC50s of 1.2, 2.5, 3.0 and 5.7 nM, respectively.
In early April of 2019, the US FDA approved Janssen Pharmaceutical Companies' brand name Balversa (erdafitinib) as the first-ever fibroblast growth factor receptor (FGFR) kinase inhibitor indicated for patients with locally advanced or metastatic urothelial carcinoma, with susceptible FGFR3 or FGFR2 genetic alterations, that has progressed during or following platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy. At the same time, the FDA also approved the therascreen FGFR RGQ RT-PCR Kit (Qiagen) for utilization as a companion diagnostic with erdafitinib for selecting patients for the indicated therapy. Erdafitinib's innovation lies in the fact that it is the first personalized treatment targeting susceptible FGFR genetic alterations for patients with metastatic bladder cancer, which demonstrates the design of erdafitinib in developing more personalized and precision medicines with the capacity to target cancer treatment to a patient's specific genetic mutation. Considering urothelial cancer is statistically the fourth most common kind of cancer in the world, the introduction of erdafitinib offers a welcome new option in the ever-expanding therapeutic tool kit to treat such prevalent medical conditions. Nevertheless, although erdafitinib was granted Breakthrough Therapy designation and Accelerated Approval from the FDA so as to allow the agency to focus on and expedite the approval process for a medication indicated for a serious condition that fills an unmet medical need using clinical trial data that is believed to predict a genuine clinical benefit for patients with the given condition, such designations mean further ongoing clinical trials are necessary to confirm the clinical benefit of erdafitinib going forward.|Erdafitinib is an oral small molecule inhibitor of fibroblast growth factor receptors (FGFR) 1 to 4 that is used in the therapy of locally advanced, unresectable or metastatic urothelial carcinoma. Erdafitinib has been associated with a high rate of serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent acute liver injury.|Erdafitinib is an orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Upon oral administration, erdafitinib binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways and thus the inhibition of tumor cell proliferation and tumor cell death in FGFR-overexpressing tumor cells. FGFR, upregulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cell proliferation, differentiation and survival.

Certificates

Basic Info

Product Name:

N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine

Other Name:

1,2-Ethanediamine,N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-;N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine;Erdafitinib;JNJ 42756493;Balversa;1620332-47-9

CAS No.:

1346242-81-6

Molecular Formula:

C25H30N6O2

InChIKeys:

InChIKey=OLAHOMJCDNXHFI-UHFFFAOYSA-N

Molecular Weight:

446.54

Exact Mass:

446.54

UNII:

890E37NHMV

NCI Thesaurus Code:

C103273

ATC Code:

L - Antineoplastic and immunomodulating agents

Categories:

Antineoplastic Agents

Characteristics

PSA:

77.3

XLogP3:

3.2

Density:

1.2±0.1 g/cm3

Flash Point:

354.4±31.5 °C

Refractive Index:

1.618

Water Solubility:

<1 mg/mL

See More N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine Properties 

Hazard Identification

Classification of the substance or mixture

Acute toxicity - Category 4, Oral

Skin sensitization, Sub-category 1B

Serious eye damage, Category 1

Reproductive toxicity, Category 2

Specific target organ toxicity â repeated exposure, Category 1

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)
Signal word	Danger
Hazard statement(s)	H302 Harmful if swallowed H317 May cause an allergic skin reaction H318 Causes serious eye damage H361 Suspected of damaging fertility or the unborn child H372 Causes damage to organs through prolonged or repeated exposure
Prevention	P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/... P203 Obtain, read and follow all safety instructions before use. P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response	P301+P317 IF SWALLOWED: Get medical help. P330 Rinse mouth. P302+P352 IF ON SKIN: Wash with plenty of water/... P333+P317 If skin irritation or rash occurs: Get medical help. P321 Specific treatment (see ... on this label). P362+P364 Take off contaminated clothing and wash it before reuse. P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P317 Get medical help. P318 IF exposed or concerned, get medical advice. P319 Get medical help if you feel unwell.
Storage	P405 Store locked up.
Disposal	P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine Safety Data Sheet 

Seller Information

Business Type:
Trader

Main Products:
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

Location:
Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
10

Total Annual Revenue:
$5 million-$10 million

Total Employees:
11-50

Year of Establishment:
2013

Certifications:
Certification Report by Bureau Veritas

About HyperChem

Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

Our Competitiveness

One-stop supply

Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

Among all the pharmaceuticals,

90% of them with GMP certificates,

85% of them with DMF files and

50% of them passed FDA approval,

30% get CEP certificate

20% are new R&D products.

Custom Repackaging Service

We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

Quality Control/Quality Assurance

HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

Professional

Transparent Communication

Fast Reaction,

Professional Suggestion

Beyond Expectation.

We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

Inquiry History

215 Inquiries

Country	Product	Purchase Quantity	Date Posted
Vietnam	High Quality Erdafitinib 99% powder 1346242-81-6 Erdafitinib	1 G	Aug 18, 2026
United States	High Quality Erdafitinib 99% powder 1346242-81-6 Erdafitinib	1 G	Jul 26, 2026
Australia	High Quality Erdafitinib 99% powder 1346242-81-6 Erdafitinib	1 G	Aug 14, 2026
Poland	High Quality Erdafitinib 99% powder 1346242-81-6 Erdafitinib	1 G	Jul 28, 2026
United States	Hot Selling ERDAFITINIB 1346242-81-6 Factory Supply Raw Materials High Qulity Wholesale price	3 MT	Jul 5, 2026
Australia	Erdafitinib	1 G	Jul 18, 2026
Germany	Erdafitinib	500 MG	Jul 28, 2026
Cyprus	Erdafitinib	1 G	Jul 22, 2026
Bulgaria	Erdafitinib	500 MG	Jun 18, 2026
Switzerland	1g Erdafitinib raw powder >99% purity	1 G	May 22, 2026
Georgia	Erdafitinib	1 G	Aug 19, 2026
Suriname	Erdafitinib	1 G	Aug 19, 2026
Argentina	Erdafitinib	1 G	Aug 16, 2026
United States	Erdafitinib	1 G	Aug 16, 2026
Australia	High Quality Erdafitinib 99% powder 1346242-81-6-Shaanxi Dideu Medichem Co.Ltd	1 G	Aug 15, 2026
United States	Erdafitinib	1 G	Aug 14, 2026
Germany	Erdafitinib	1 G	Aug 14, 2026
Canada	Erdafitinib	1 G	Aug 14, 2026
United States	Erdafitinib	1 G	Aug 14, 2026
Canada	Erdafitinib	1 MT	Aug 11, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
ERDAFITINIB high quality	/	$1-1.3/BOU FOB	Nanjing Paron Technology Co., Ltd	Inquiry
N1-(3,5-Dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine 99%	/		Conier Chem&Pharma Limited	Inquiry
Erdafitinib 1346242-81-6	/	$10-11/G FOB	Shandong zhishang chemical Co.,Ltd	Inquiry
ERDAFITINIB 98% yellow powder 1346242-81-6 Senwayer	Pharmaceutical Grade/98		Dingwang Technology (Wuhan) Co., Ltd.	Inquiry
ERDAFITINIB zhishang	/	$60-65/G FOB	SHANDONG LOOK CHEMICAL CO.,LTD	Inquiry